Developing vaccines to fight antibiotic-resistant bacteria
Official title: Advanced Development of Vaccines for Antibiotic Resistant Bacteria
Funded at Eveliqure Biotechnologies, Gmbh · NIH-10880209 · Data updated 2026-11-12
This study is working on developing vaccines to help protect people from infections caused by bacteria that don't respond to regular antibiotics, and it's aimed at making sure these vaccines are safe and effective for future use in humans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Eveliqure Biotechnologies, Gmbh NIH-funded |
| Lab location | 1 site (Veinna, Austria) |
| Project start | September 1, 2020 |
| Project end | February 28, 2026 |
| Funding year | 2023 |
| Award (this year) | $3,490,104 |
| NIH project number | 75N93020C00048-P00007-9999-1 |
| Project ID | NIH-10880209 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of infections from antibiotic-resistant bacteria, including those with weakened immune systems or underlying health conditions.
✕Less likely to help
Patients who are not at risk of antibiotic-resistant infections or those who are already infected with such bacteria may not benefit from this research.
What this research studies
This research focuses on creating vaccines to combat infections caused by antibiotic-resistant bacteria, particularly in response to outbreaks. It involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness and safety in animal models. The ultimate goal is to prepare these vaccines for clinical trials to ensure they are safe and effective for human use.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from serious infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Other research has shown promise in developing vaccines for infectious diseases, but this specific approach targeting antibiotic-resistant bacteria is relatively novel.
Where this research is happening
-
Eveliqure Biotechnologies, Gmbh
Veinna, Austria Active
Researchers
- Principal investigator: Malinowski, Frank — Eveliqure Biotechnologies, Gmbh
- Study coordinator: Malinowski, Frank
Related research
Other NIH-funded projects on the same topics.
-
Developing vaccines to fight antibiotic-resistant bacteria
This study is working on a new vaccine to help fight bacteria that don't respond to regular antibiotics, and it will eventually involve people to see how safe and effective the vaccine is.
-
Developing vaccines to fight antibiotic-resistant bacteria
This study is working on new vaccines to help fight infections caused by bacteria that don't respond to regular antibiotics, and it's designed for people who want to help improve treatments for serious infections.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.